O&G Vivas · Early pregnancy care — recurrent loss
Recurrent pregnancy loss — structured oral station (12 minutes)
FRANZCOG oral-format station on recurrent pregnancy loss: focused history taking, the four-test panel and the deliberate refusals, antiphospholipid syndrome criteria and treatment, the progesterone subgroup, and counselling an informed, anxious couple. Scored against the eight published RANZCOG oral domains.
On this page
Study tools
Target exams
Station format
4 minutes reading, 12 minutes examination, 20 marks, global scoring. The eight published RANZCOG oral domains apply: history and examination; investigations and interpreting results; treatment and management; clinical knowledge; complex, urgent or unusual presentations; rapport with patient, support person or colleague; respect; communication skills. This couple is informed and anxious — the history-taking and the rapport domains matter as much as the test list. [1]
Reveal the examiner script and model responsesShowHide
Opening prompt — "Take a focused history from her."
Model response — build a pregnancy timeline before you order anything: [1][5]
- For each pregnancy: the gestation, whether it was confirmed intrauterine, whether a fetal heart was ever seen, how it ended, and whether tissue was examined. Sequence matters for the prognosis.[1]
- Ask about the pattern: a fetal death at or after 10 weeks, or severe early preeclampsia before 34 weeks, points toward antiphospholipid syndrome; a painless mid-trimester loss with a live fetus points toward cervical insufficiency rather than recurrent early loss.[3]
- The partner: paternal age, smoking, alcohol, weight — ESHRE 2023 upgraded the male assessment to a recommendation.[1]
- Acknowledge her folder and her reading. Say you will go through her list with her. Refusing her tests without explaining loses the consultation.[5]
Probe 1 — "Which tests will you order, and which will you refuse?"
- "Four tests are routinely recommended: lupus anticoagulant, anticardiolipin antibodies, thyroid function with thyroid peroxidase antibodies, and a 3D pelvic ultrasound."[21]
- "I will not order inherited thrombophilia testing — ALIFE2 showed heparin does not help and advises against screening. I will not measure natural killer cells, cytokines or HLA typing — no evidence of benefit, and false positives cause anxiety. And I will not routinely test vitamin D or ovarian reserve."[1][4]
- "For the natural killer cell test she brought: I would explain what it measures and why it is not routinely recommended — there is no validated biomarker for immune-mediated loss — and what we will do instead."[1][21]
Probe 2 — "Her lupus anticoagulant is positive. What now?"
- "I will not diagnose antiphospholipid syndrome on one result. The laboratory criterion requires the antibody to be present on two or more occasions at least 12 weeks apart — so I repeat it at least 12 weeks later, confirming the timing with the laboratory."[3][21][22]
- "If it is confirmed, with a clinical criterion met, the treatment is aspirin 75 to 150 mg daily started before or at the positive pregnancy test, plus low-molecular-weight heparin from the positive test continued to at least 34 weeks — a strong recommendation on moderate evidence."[21]
Probe 3 — "She asks about progesterone for the next pregnancy."
- "Progesterone is not for a history of losses alone. PROMISE gave first-trimester micronised vaginal progesterone to women with unexplained recurrent miscarriage and found no benefit — live birth 65.8 per cent versus 63.3 per cent."[16]
- "But if she bleeds in the next pregnancy, the subgroup of women with previous loss and current bleeding showed a benefit. RANZCOG then recommends micronised vaginal progesterone 400 mg twice daily to 16 weeks. The indication is bleeding plus previous losses, not history alone."[1][21]
Probe 4 — "Tell her about the prognosis."
- "Most couples in her situation go on to have a baby — in PROMISE, nearly two-thirds of women with unexplained loss had a live birth on placebo. After a full workup, many have no identified cause — and that is the expected result, not a failure. The prognosis is based on her age and her complete pregnancy history, not the loss count alone."[1][5][16]
- "The next pregnancy is the treatment: an early reassurance scan, progesterone if she bleeds, antiphospholipid treatment if confirmed, a named clinician, and a defined route back into the service. Continuity of care in a dedicated clinic is the plan."[1][5]
Probe 5 — "She asks when to stop trying."
References8ShowHide
- [1]Bender Atik R, Christiansen OB, Elson J, et al. ESHRE guideline: recurrent pregnancy loss: an update in 2022 Hum Reprod Open, 2023.PMID 36873081
- [2]Regan L, Rai R, Saravelos S, Li TC; Royal College of Obstetricians and Gynaecologists Recurrent MiscarriageGreen-top Guideline No. 17 BJOG, 2023.PMID 37334488
- [3]Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost, 2006.PMID 16420554
- [4]Quenby S, Booth K, Hiller L, et al. Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial Lancet, 2023.PMID 37271152
- [5]Coomarasamy A, Dhillon-Smith RK, Papadopoulou A, et al. Recurrent miscarriage: evidence to accelerate action Lancet, 2021.PMID 33915096
- [16]Coomarasamy A, Williams H, Truchanowicz E, et al. A Randomized Trial of Progesterone in Women with Recurrent Miscarriages N Engl J Med, 2015.PMID 26605928
- [21]Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Miscarriage, Recurrent Miscarriage and Ectopic Pregnancy (C-Gyn 38), Clinical Guideline, Version 1. RANZCOG, 2025.Source
- [22]Doyle AJ, Cox C, Breen KA Antiphospholipid syndrome and pregnancy-a hematologic perspective. Res Pract Thromb Haemost, 2026.PMID 41890553